MedTrace Logo

Long-term Efficacy and Safety Research of Left Bundle Branch Pacing

NCT05600699 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 136

Last updated 2022-11-01

No results posted yet for this study

Summary

Patients with successful left bundle branch pacing in our center were included in this study from April 2018 to December 2019. Baseline data was collected, and pacing parameters, ECG and echocardiographic results were analyzed during 3 years follow-up. According to whether or not a potential was recorded and the specific potential characteristics at implantation, the patients were divided into 3 groups: left bundle branch potential group; Purkinje potential group; and no-potential group. During the 3 years follow-up, the investigators collected the ECG、UCG and pacemaker parameters to analyze.

Conditions

  • Atrioventricular Block
  • Left Bundle Branch Pacing

Interventions

DEVICE

Cardiac pacemaker and Select Secure lead

model 3830, 69cm, Medtronic, Inc., Minneapolis, MN, USA

Sponsors & Collaborators

  • Linyi People's Hospital

    lead OTHER

Principal Investigators

  • Fingming Li · Linyi People's Hospital

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2019-12-31
Completion
2022-10-01
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05600699 on ClinicalTrials.gov